Zafir Sadaf, Zhou Wei, Menkhorst Ellen, Santos Leilani, Dimitriadis Evdokia
Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, 3010, Australia.
Gynaecology Research Centre, Royal Women's Hospital, Level 7, The Royal Women's Hospital, 20 Flemington Road, Parkville, Victoria, 3052, Australia.
Fertil Res Pract. 2021 Mar 27;7(1):8. doi: 10.1186/s40738-021-00100-y.
Abnormalities in endometrial receptivity has been identified as a major barrier to successful embryo implantation. Endometrial receptivity refers to the conformational and biochemical changes occurring in the endometrial epithelial layer which make it adhesive and receptive to blastocyst attachment. This takes place during the mid-secretory phase of woman's menstrual cycle and is a result of a delicate interplay between numerous hormones, cytokines and other factors. Outside of this window, the endometrium is refractory to an implanting blastocyst. It has been shown that Notch ligands and receptors are dysregulated in the endometrium of infertile women. Mastermind Like Transcriptional Coactivator 1 (MAML1) is a known coactivator of the Notch signaling pathway. This study aimed to determine the role of MAML1 in regulating endometrial receptivity.
The expression and localization of MAML1 in the fertile human endometrium (non-receptive proliferative phase versus receptive mid-secretory phase) were determined by immunohistochemistry. Ishikawa cells were used as an endometrial epithelial model to investigate the functional consequences of MAML1 knockdown on endometrial adhesive capacity to HTR8/SVneo (trophoblast cell line) spheroids. After MAML1 knockdown in Ishikawa cells, the expression of endometrial receptivity markers and Notch dependent and independent pathway members were assessed by qPCR. Two-tailed unpaired or paired student's t-test were used for statistical analysis with a significance threshold of P < 0.05.
MAML1 was localized in the luminal epithelium, glandular epithelium and stroma of human endometrium and the increased expression identified in the mid-secretory phase was restricted only to the luminal epithelium (P < 0.05). Functional analysis using Ishikawa cells demonstrated that knockdown of MAML1 significantly reduced epithelial adhesive capacity (P < 0.01) to HTR8/SVneo (trophoblast cell line) spheroids compared to control. MAML1 knockdown significantly affected the expression of classical receptivity markers (SPP1, DPP4) and this response was not directly via hormone receptors. The expression level of Hippo pathway target Ankyrin repeat domain-containing protein 1 (ANKRD1) was also affected after MAML1 knockdown in Ishikawa cells.
Our data strongly suggest that MAML1 is involved in regulating the endometrial adhesive capacity and may facilitate embryo attachment, either directly or indirectly through the Notch signaling pathway.
子宫内膜容受性异常已被确定为胚胎成功着床的主要障碍。子宫内膜容受性是指子宫内膜上皮层发生的构象和生化变化,使其具有黏附性并能接受囊胚附着。这发生在女性月经周期的分泌中期,是多种激素、细胞因子和其他因素之间微妙相互作用的结果。在此窗口期之外,子宫内膜对植入的囊胚具有抵抗性。研究表明,不育女性的子宫内膜中Notch配体和受体表达失调。主调控分子样转录共激活因子1(MAML1)是Notch信号通路中一种已知的共激活因子。本研究旨在确定MAML1在调节子宫内膜容受性中的作用。
通过免疫组织化学法确定MAML1在 fertile human endometrium(非容受性增殖期与容受性分泌中期)中的表达和定位。采用 Ishikawa 细胞作为子宫内膜上皮模型,研究 MAML1 敲低对子宫内膜与 HTR8/SVneo(滋养层细胞系)球体黏附能力的功能影响。在 Ishikawa 细胞中敲低 MAML1 后,通过 qPCR 评估子宫内膜容受性标志物以及 Notch 依赖性和非依赖性途径成员的表达。采用双侧不成对或配对学生 t 检验进行统计分析,显著性阈值为 P < 0.05。
MAML1 定位于人子宫内膜的腔上皮、腺上皮和基质中,分泌中期表达增加仅局限于腔上皮(P < 0.05)。使用 Ishikawa 细胞进行的功能分析表明与对照组相比,敲低 MAML1 显著降低了上皮细胞与 HTR8/SVneo(滋养层细胞系)球体的黏附能力(P < 0.01)。敲低 MAML1 显著影响经典容受性标志物(SPP1、DPP4)的表达,且这种反应并非直接通过激素受体。在 Ishikawa 细胞中敲低 MAML1 后,Hippo 通路靶点含锚蛋白重复结构域蛋白1(ANKRD1)的表达水平也受到影响。
我们的数据强烈表明,MAML1 参与调节子宫内膜的黏附能力,可能直接或通过 Notch 信号通路间接促进胚胎附着。